Unlock instant, AI-driven research and patent intelligence for your innovation.

Novel oral delivery composition containing liraglutide derivative and application of novel oral delivery composition

A technology of liraglutide and composition, applied in the field of oral delivery composition, can solve the problems of inconvenient administration frequency and subcutaneous administration, poor patient compliance, short duration, etc., achieve good oral bioavailability efficiency, reduce painful effect

Pending Publication Date: 2021-06-18
南京诺文海泰生物医药有限公司
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, the hypoglycemic duration of liraglutide is relatively short, and it can only continuously activate the GLP-1 receptor within one day, resulting in inconvenience in the frequency of administration and subcutaneous administration, and poor patient compliance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Novel oral delivery composition containing liraglutide derivative and application of novel oral delivery composition
  • Novel oral delivery composition containing liraglutide derivative and application of novel oral delivery composition
  • Novel oral delivery composition containing liraglutide derivative and application of novel oral delivery composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0042] 1. Synthesis of chemically modified lysine

[0043] 1.1. Weigh 20g of Wang resin with a substitution degree of 1.0mmol / g, add it to a solid-phase reaction column, wash it twice with DMF, and swell the resin with DMF for 30 minutes, take 9.05g of Fmoc-Lys(Alloc)-OH for use DMF was dissolved, activated by adding 6.65mL DIEA in an ice-water bath, and then added to the above-mentioned reaction column filled with resin. After 2 hours of reaction, 10mL of anhydrous methanol was added to block for 1 hour. Wash 3 times with DMF and 3 times with DCM, then block with anhydrous methanol for 30 minutes, shrink and dry with methanol to obtain Fmoc-Lys(Alloc)-Wang resin, the detection degree of substitution is 0.605mmol / g.

[0044] 1.2. Weigh 10.0g (6.0mmol) of Fmoc-Lys(Alloc)-Wang resin with a substitution degree of 0.605mmol / g, add it to the solid phase reaction column, wash it twice with DMF, and swell Fmoc-Lys(Alloc) with DMF -Wang resin 30 minutes later, add 30mL dichloromethan...

Embodiment 2

[0069] 1. Synthesis of chemically modified lysine

[0070] 1.1. Weigh 20g of Wang resin with a substitution degree of 1.0mmol / g, add it to a solid-phase reaction column, wash it twice with DMF, and swell the resin with DMF for 30 minutes, take 9.05g of Fmoc-Lys(Alloc)-OH for use Dissolve DMF, activate by adding 6.65mL DIEA in an ice-water bath, add to the above-mentioned reaction column filled with resin, react for 2 hours, add 10mL of anhydrous methanol to seal for 1 hour; wash with DMF for 3 times, DCM for 3 times, and then use After blocking with anhydrous methanol for 30 minutes, the methanol was shrunk and drained to obtain Fmoc-Lys(Alloc)-Wang resin, and the detected substitution degree was 0.605 mmol / g.

[0071] 1.2. Weigh 10.0g (6.0mmol) of Fmoc-Lys(Alloc)-Wang resin with a substitution degree of 0.605mmol / g, add it to the solid phase reaction column, wash it twice with DMF, and swell Fmoc-Lys(Alloc) with DMF -Wang resin 30 minutes later, add 30mL dichloromethane, the...

Embodiment 3

[0096] 1. Synthesis of chemically modified lysine

[0097] 1.1. Weigh 20g of Wang resin with a substitution degree of 1.0mmol / g, add it to a solid-phase reaction column, wash it twice with DMF, and swell the resin with DMF for 30 minutes, take 9.05g of Fmoc-Lys(Alloc)-OH for use Dissolve DMF, activate by adding 6.65mL DIEA in an ice-water bath, add to the above-mentioned reaction column filled with resin, react for 2 hours, add 10mL of anhydrous methanol to seal for 1 hour; wash with DMF for 3 times, DCM for 3 times, and then use After blocking with anhydrous methanol for 30 minutes, the methanol was shrunk and drained to obtain Fmoc-Lys(Alloc)-Wang resin, and the detected substitution degree was 0.605 mmol / g.

[0098] 1.2. Weigh 10.0g (6.0mmol) of Fmoc-Lys(Alloc)-Wang resin with a substitution degree of 0.605mmol / g, add it to the solid phase reaction column, wash it twice with DMF, and swell Fmoc-Lys(Alloc) with DMF -Wang resin 30 minutes later, add 30mL dichloromethane, the...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to an oral delivery composition. The oral delivery composition comprises liraglutide derived polypeptide and N-(8-(2-hydroxybenzoyl) amino) caprylate; and the mass ratio of the liraglutide derived polypeptide to the N-(8-(2-hydroxybenzoyl) amino) caprylate is 1: (10-120). By changing the length of the liraglutide original aliphatic chain and creatively introducing carboxyl into the tail end of the aliphatic chain, compared with the aliphatic chain without the carboxyl tail end, the aliphatic acid with the carboxyl tail end has good oral bioavailability, can reduce the pain of a patient caused by multiple subcutaneous administration, and has practicability, and a new breakthrough is brought to the field of diabetes treatment.

Description

technical field [0001] The present invention relates to a class of novel oral delivery compositions containing liraglutide derivatives and applications thereof, specifically comprising liraglutide derivatives and N-(8-(2-hydroxybenzoyl)amino) octanoate Compositions and their uses, including their use in the field of diabetes treatment, are in the field of oral delivery compositions. Background technique [0002] Diabetes is the third chronic non-communicable disease that seriously threatens human health after tumors and cardiovascular diseases. Currently, there are about 300 million diabetics in the world, which is expected to increase to 500 million by 2025. Clinically, intensive insulin therapy is used to delay the progression of diabetes, but insulin injections have the risk of hypoglycemia. The therapeutic effect is affected by factors such as dose, injection site, and injection route, and there are large individual differences. If insulin is used carelessly, severe hy...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K38/26A61K47/54A61K9/00A61P3/10
CPCA61K9/0053A61K38/26A61K47/54A61P3/10
Inventor 钱海石炜邱倩倩蔡衍
Owner 南京诺文海泰生物医药有限公司